Ledger.Open graph →
SEC Form D · filed December 2, 2014

Seres Health, Inc

Offering
$48.0M
Sold
$48.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Leen Kawas · Seattle, WADirectorDavid J. Berry · Cambridge, MADirectorNathaniel Talbott · DURHAM, NCExec · DirectorPeter B. Hutt · Cambridge, MADirectorPedro Zevallos · Dallas, TXExecDavid C. Noshay · MILWAUKEE, WIDirectorJustin Benson · DURHAM, NCDirectorJohn L. Turner · Dallas, TXExec · DirectorJoseph W. Harding · Seattle, WADirectorTravis L. Furr · Dallas, TXExec · DirectorRoger J. Pomerantz · Cambridge, MAExec · DirectorEric D. Shaff · Cambridge, MAExecChristian O'Melia · DURHAM, NCDirectorLorence B. Kim · Cambridge, MADirectorRichard B. Kender · Cambridge, MADirectorDavid D. Cook · Cambrdige, MAExecJohn D. Aunins · Cambridge, MAExecWerner J. Cautreels · Cambridge, MADirectorNoubar J. Afeyan · Cambridge, MADirectorKings Peak Partners LLC · NEW YORK, NYExec · DirectorWade Kenny · San Mateo, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗